StockData
VCRENasdaqPharmaceutical PreparationsFiscal year ends December 31

Vicore Pharma Holding AB

$8.85−0.13 (-1.45%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Vicore Pharma Holding AB revenue by segment

No segment breakdown reported

Vicore Pharma Holding AB does not break out revenue by segment, region or product in the tagged data of its filings for this period type.